EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Case Report: Balloon aortic valvuloplasty with subsequent Impella support as bridge therapy to transcatheter aortic valve replacement in cardiogenic shock with severe aortic stenosis

Yukihiro Watanabe, Jun Nakata, Hiroki Matsushita, Keita Saku, Kosuke Mozawa, Toshiki Seki, Yukichi Tokita, Yuki Izumi, Masayuki Tsutsumi, Yu Hoshika, Tokuhiro Kimura, Masaaki Hino und 4 weitere

Frontiers in Cardiovascular Medicine · 22.05.2025 · 12

DOI: 10.3389/fcvm.2025.1583801 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 22.05.2025. Verfasst von Yukihiro Watanabe und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Intensive Care, Nippon Medical School Hospital, Tokyo, Japan. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cardiogenic shock (CS) with severe aortic stenosis (AS) is a drug-resistant hemodynamically unstable condition with high mortality. We report three cases of CS with severe AS that were successfully managed with balloon aortic valvuloplasty (BAV), followed by left ventricular (LV) unloading using Impella as a bridge therapy for transcatheter aortic valve replacement (TAVR). We call this therapeutic approach “BAV-PELLA-TAVR”. Case presentation Case 1: A 92-year-old Japanese female presented with CS due to low-flow, low-gradient severe AS and multivessel coronary artery disease. After emergent BAV and Impella 2.5 support, the patient's hemodynamics stabilized. Percutaneous coronary intervention was performed on the right coronary and left anterior descending arteries with Impella 2.5 support. Subsequently, her heart failure (HF) improved and elective TAVR was performed. Case 2: An 89-year-old Japanese female presented with CS due to severe AS. Despite administration of high-dose catecholamines, the patient developed exacerbation of CS due to reduced cardiac output, corresponding to Stage D according to the Society for Cardiovascular Angiography and Interventions (SCAI) classification. Consequently, BAV was performed, which reduced the aortic valve pressure gradient (PG). However, due to persistent hemodynamic instability, Impella 2.5 support was initiated. This procedure resulted in hemodynamic improvement and elective TAVR was performed. Case 3: An 86-year-old Japanese female developed CS with pulmonary edema due to severe AS. Emergent BAV was performed. However, there was no improvement in the PG and hemodynamics, and the initial mild aortic regurgitation worsened to a moderate degree. Therefore, an Impella CP was implanted, which resulted in improved hemodynamics. Following the removal of the Impella CP device, and sub-emergent TAVR was successfully performed.

Discussion

In all cases, emergent BAV and subsequent hemodynamic support from the Impella were provided as the initial treatment for CS at Stage C/D according to the SCAI classification. This approach improved CS, enabling interventions for concomitant ischemic heart disease, multidisciplinary heart team evaluation, and TAVR with reduced perioperative risk.

Schlagwörter

Stichwörter der Autor:innen

BAV-PELLA-TAVRballoon aortic valvuloplastycardiogenic shockimpellasevere aortic stenosistranscatheter aortic valve replacement

Autor:innen und Institutionen

  • Division of Cardiovascular Intensive Care, Nippon Medical School Hospital, Tokyo, Japan.
  • Department of Cardiovascular Dynamics, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan.
  • Department of Cardiovascular Medicine, Nippon Medical School, Tokyo, Japan.

Zitieren

APA

Watanabe, Y., Nakata, J., Matsushita, H., Saku, K., Mozawa, K., Seki, T., Tokita, Y., Izumi, Y., Tsutsumi, M., Hoshika, Y., Kimura, T., Hino, M., Shiomura, R., Sangen, H., Yamamoto, T., & Asai, K. (2025). Case Report: Balloon aortic valvuloplasty with subsequent Impella support as bridge therapy to transcatheter aortic valve replacement in cardiogenic shock with severe aortic stenosis. Frontiers in Cardiovascular Medicine, 12. https://doi.org/10.3389/fcvm.2025.1583801

Vancouver

Watanabe Y, Nakata J, Matsushita H, Saku K, Mozawa K, Seki T, et al. Case Report: Balloon aortic valvuloplasty with subsequent Impella support as bridge therapy to transcatheter aortic valve replacement in cardiogenic shock with severe aortic stenosis. Frontiers in Cardiovascular Medicine. 2025;12. doi:10.3389/fcvm.2025.1583801

BibTeX
@article{Watanabe2025,
  author = {Watanabe, Yukihiro and Nakata, Jun and Matsushita, Hiroki and Saku, Keita and Mozawa, Kosuke and Seki, Toshiki and Tokita, Yukichi and Izumi, Yuki and Tsutsumi, Masayuki and Hoshika, Yu and Kimura, Tokuhiro and Hino, Masaaki and Shiomura, Reiko and Sangen, Hideto and Yamamoto, Takeshi and Asai, Kuniya},
  title = {Case Report: Balloon aortic valvuloplasty with subsequent Impella support as bridge therapy to transcatheter aortic valve replacement in cardiogenic shock with severe aortic stenosis},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2025},
  volume = {12},
  doi = {10.3389/fcvm.2025.1583801}
}
Kostenlos starten →